Pular para o conteúdo
Encefalite autoimune
ORPHA:622014DOENÇA RARA
neuro
Também conhecida comoAIEAEAIE
Sinônimos clínicos: AE · AIE

Inflamação do cérebro secundária a uma resposta imunológica desencadeada pelo próprio corpo.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A encefalite autoimune é uma inflamação no cérebro que acontece quando as próprias defesas do corpo atacam o sistema nervoso. O quadro costuma causar alterações de comportamento, confusão mental, problemas de memória e crises convulsivas. No Brasil, a condição não consta na lista oficial de diretrizes (PCDTs) de doenças raras do Ministério da Saúde, sendo o cuidado conduzido pela rede especializada do SUS. O diagnóstico exige investigação com exames do líquor da espinha, eletroencefalograma e rastreamento de autoanticorpos.

📋
Informacoes curadas por IA — podem conter imprecisoes

Inflamação do cérebro secundária a uma resposta imunológica desencadeada pelo próprio corpo.

Pesquisas ativas
36 ensaios
70 total registrados no ClinicalTrials.gov
Publicações científicas
4.183 artigos
Último publicado: 2026
Em pesquisa
4 moléculas
METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE HEMISUCCINATE, INEBILIZUMAB

O que está sendo pesquisado

4 moléculas em estudo — nenhuma com registro para esta doença
Ver detalhes e fases →
METHYLPREDNISOLONE SODIUM SUCCINATEMETHYLPREDNISOLONE HEMISUCCINATEINEBILIZUMABOCRELIZUMAB
Aparecer aqui significa que a molécula foi estudada nesta doença, não que trate. Converse com seu médico.
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
14 sintomas
🛡️
Imunológico
3 sintomas
🩸
Sangue
2 sintomas
📏
Crescimento
2 sintomas
🫃
Digestivo
1 sintomas
🦷
Dentes
1 sintomas

+ 21 sintomas em outras categorias

Características mais comuns

—
EEG com atividade lenta focal
—
Pleocitose do LCR
—
Tomografia por emissão de pósitrons com FDG cerebral anormal
—
Irritabilidade
—
Ansiedade
—
Bandas oligoclonais de imunoglobulina G no LCR
44sintomas
Sem dados (44)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 44 características clínicas mais associadas, ordenadas por frequência.

EEG com atividade lenta focalEEG with focal slow activity
Pleocitose do LCRCSF pleocytosis
Tomografia por emissão de pósitrons com FDG cerebral anormalAbnormal brain FDG positron emission tomography
IrritabilidadeIrritability
AnsiedadeAnxiety

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico4.183PubMed
Últimos 10 anos200publicações
Pico2026142 papers
Linha do tempo
2026Hoje · 2026🧪 2015Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado2
3Fase 34
2Fase 214
1Fase 18
·Pré-clínico46
Medicamentos catalogadosEnsaios clínicos· 4 medicamentos · 70 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Encefalite autoimune

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 12 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

21 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT07707739 · Plasma Exchange in Pediatric Autoimmune EncephalitisRecrutando
NA🇪🇬 Egito
NCT07093333 · A Study in Participants With Anti-NMDAR Encephalitis and Ant…Recrutando
PHASE2South Korea
NCT07526493 · Safety and Pharmacodynamics of QH103 Cell Injection in the T…Recrutando
PHASE1🇨🇳 China
NCT07488117 · Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in A…Recrutando
PHASE2🇫🇷 França
NCT07337785 · CD19/BCMA-Targeted UCAR-T for Patients With Neurological Aut…Recrutando
EARLY_PHASE1🇨🇳 China
NCT07158229 · Long-term Impact of NMDAR Encephalitis, Level 3Recrutando
🇫🇷 França
NCT07477015 · Study of Pathogenic Mechanisms and Identification of Novel A…Recrutando
🇮🇹 Itália
NCT06939166 · Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) The…Recrutando
EARLY_PHASE1🇨🇳 China
NCT06584045 · Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adul…Recrutando
NA🇨🇳 China
NCT07133113 · Medium-term Effects of Treatments in Autoimmune EncephalitisRecrutando
🇫🇷 França
NCT06502015 · Biomarkers in Autoimmune Disease of Nervous SystemRecrutando
🇨🇳 China
NCT06079294 · Impact of Confirmed Autoimmune Encephalitis on Brain Glucose…Recrutando
NA🇫🇷 França
NCT07653984 · Cohort Study on Neuroimmune Diseases in the Reproductive AgeRecrutando
🇨🇳 China
NCT06019975 · FDG-PET in the Diagnosis of Autoimmune EncephalitisRecrutando
🇮🇹 Itália
NCT05198661 · Paraneoplastic Neurological Syndromes and Autoimmune Encepha…Recrutando
NA🇫🇷 França
NCT06173076 · A Prospective Study to Evaluate Clinical Outcomes in Anti-LG…Recrutando
🇨🇳 China
NCT04372615 · The ExTINGUISH Trial of Inebilizumab in NMDAR EncephalitisRecrutando
PHASE2🇳🇱 Países Baixos · 🇪🇸 Espanha · 🇺🇸 Estados Unidos
NCT05772611 · Characterization of Immune-response in Autoimmune Encephalit…Recrutando
🇫🇷 França
NCT04561557 · Safety and Efficacy of CT103A Cells for Relapsed/Refractory …Recrutando
EARLY_PHASE1🇨🇳 China
NCT03993262 · Trial to Evaluate Efficacy and Safety of Bortezomib in Patie…Recrutando
PHASE2🇩🇪 Alemanha
NCT05017142 · Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-P…Recrutando
🇨🇭 Suíça

Outros ensaios clínicos

70 ensaios clínicos encontrados, 36 ativos.

Distribuição por fase
NCT07583641 · A Study to Learn About How Well the Medicine Efgartigimod Wo…Em breve
PHASE2🇺🇸 Estados Unidos
NCT07783269 · A Basket Study of CTA313 in Participants With Active Autoimm…Em breve
PHASE1
NCT07858175 · Clinical Evaluation of a Novel DAB Chromogenic Tissue-Based …Em breve
🇨🇳 China
NCT07804004 · A Safety and Efficacy Study Evaluating CTX112 in Subjects Wi…Em breve
PHASE1, PHASE2
NCT07686042 · Efficacy and Safety of Low-Dose Blinatumomab in the Treatmen…Em breve
PHASE4🇨🇳 China
NCT07333196 · Tongji NADs CohortEm breve
🇨🇳 China
NCT07341828 · A Study of C-CAR168 in the Treatment of Central Nervous Syst…Em breve
PHASE1
NCT07131683 · hUC-MSC-Exo Therapy for Autoimmune EncephalitisEm breve
PHASE1, PHASE2
NCT06760091 · A Multicentric Cohort of Autoimmune EncephalitisEm breve
🇨🇳 China
NCT06697678 · Risk Prediction Model for Severe Autoimmune EncephalitisEm breve
NCT05503264 · A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (…Ativo
PHASE3🇧🇷 Brasil · 🇦🇷 Argentina · 🇨🇳 China +12
NCT07689682 · OPM- MEG in Non-immune And iMmune-medIated Neurological Dise…Ativo
NA🇬🇧 Reino Unido
NCT07145502 · Monitoring of Outcomes of Cellular and Exosome-based Therapi…Ativo
🇵🇱 Polônia
NCT05728931 · New Biomarkers in Auto-immune Encephalitis and Neurological …Ativo
🇫🇷 França
NCT03194815 · IVIG and Rituximab in Antibody-associated Psychosis - SINAPP…Ativo
PHASE2🇬🇧 Reino Unido
NCT06753955 · Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy…Concluído
PHASE1🇦🇺 Austrália
NCT06609044 · Long-term Impact of NMDAR EncephalitisConcluído
🇫🇷 França
NCT06575153 · Phase 1 Study of ART5803 in Healthy ParticipantsConcluído
PHASE1🇦🇺 Austrália
NCT06033846 · Efficacy and Safety of Adjunctive Minocycline in the Treatme…Concluído
PHASE2🇨🇳 China
NCT05825690 · BRIEF TITLE * (in English and Sufficiently Descriptive) Role…Concluído
🇫🇷 França
NCT07036042 · Clinical Characteristics of Patients With Anti-Collapsin Res…Concluído
🇨🇳 China
NCT05741619 · Long-term Follow up of Patient With Anti-GABAbr Antibodies A…Concluído
🇫🇷 França
NCT05645185 · Characterisation of Clinical Phenotypes and Outcomes of Ma2 …Concluído
🇫🇷 França
NCT05783947 · Diagnostic Performance of a Commercial Assay for the Detecti…Concluído
🇫🇷 França
NCT03542279 · CPI Combination Therapy for Autoimmune EncephalitisConcluído
NA🇨🇳 China
NCT03872284 · Neuro-ophthalmology and Autoimmune Encephalitis (NODE)Concluído
🇫🇷 França
NCT04175522 · Safety and Efficacy of IGIV 10% in Patients With Autoimmune …Concluído
PHASE2South Korea
NCT04708626 · Epidemiology of Autoimmune Encephalitides and Paraneoplastic…Concluído
🇸🇪 Suécia
NCT05605223 · Study of Acute Autoimmune Encephalitis With Positive Antibod…Concluído
🇫🇷 França
NCT02905136 · Mechanisms of Auto-immune EncephalitisConcluído
🇫🇷 França
NCT03530462 · To Explore Cognitive Neural Mechanism of Autoimmune Encephal…Concluído
🇨🇳 China
NCT07722286 · Relapse and Functional Outcomes in Anti-LGI1 EncephalitisConcluído
🇨🇳 China
NCT06456736 · Clinical Features and Prognostic Markers in Adult Patients W…UNKNOWN
NCT06432803 · Metabolic Imaging for Diagnosis and Prognostication of Autoi…UNKNOWN
🇫🇷 França
NCT05711563 · Predicting and Monitoring Outcomes in Autoimmune Encephaliti…UNKNOWN
NCT06245447 · Brain MRI Longitudinal Volumetric Characteristics Associated…UNKNOWN
🇫🇷 França
NCT05953974 · Validation of a Diagnostic Score for Encephalitis to Assess …UNKNOWN
🇫🇷 França
NCT05280600 · Developing Advanced Neuroimaging for Clinical Evaluation of …UNKNOWN
🇬🇧 Reino Unido
NCT05177939 · Phase III Clinical Study of NPB-01 in Patients With Autoimmu…UNKNOWN
PHASE3🇯🇵 Japão
NCT04823728 · HLA Analysis in Autoimmune Encephalitis and Related Disorder…UNKNOWN
🇫🇷 França
NCT05225883 · GWAS in NMDAR EncephalitisUNKNOWN
🇫🇷 França
NCT06443333 · National, Multicentric Registry Study on Neuroimmunological …UNKNOWN
🇨🇳 China
NCT04339127 · Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies F…UNKNOWN
🇫🇷 França
NCT04106596 · HLA Analysis in Autoimmune Encephalitis and Related Disorder…UNKNOWN
🇫🇷 França
NCT03957616 · Incidence of Paraneoplastic Neurological Syndromes and Autoi…UNKNOWN
🇫🇷 França
NCT05422664 · Acute Sympotomatic Seizure Secondary to Autoimmune Encephali…UNKNOWN
🇨🇳 China
NCT04875975 · A Study to Test the Efficacy, Safety, and Pharmacokinetics o…Encerrado
PHASE2🇦🇺 Austrália · 🇧🇪 Bélgica · 🇫🇷 França +6
NCT03835728 · Efficacy of Ocrelizumab in Autoimmune EncephalitisEncerrado
PHASE2🇺🇸 Estados Unidos
NCT03004209 · Effect of Erythropoietin in Refractory Autoimmune Encephalit…Cancelado
PHASE4South Korea
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
3.812 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 3.812

#1

Fixel-Based Analysis of Pretreatment MRI Identifies White Matter Abnormalities in Pediatric Anti-NMDAR Encephalitis.

Journal of child neurology2026 Mar 25

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder in which conventional MRI often appears normal, leading to clinical-radiologic dissociation and hindering early diagnosis and monitoring. We retrospectively studied five pediatric patients with anti-NMDAR encephalitis and compared their pretreatment diffusion MRI to age- and sex-matched controls. Using fixel-based analysis (FBA), we quantified tract-specific white matter abnormalities at the individual level. All patients showed significantly reduced fiber density and cross-section, with patterns ranging from focal to widespread involvement. In two patients, FBA abnormalities corresponded to seizure lateralization on EEG despite normal MRI, emphasizing FBA's added value in detecting seizure-concordant injury. One patient, exhibiting the highest disease burden and marked CSF pleocytosis, demonstrated extensive white matter tract disruption. These findings indicate that FBA derived from pretreatment MRI can identify clinically significant white matter injury at disease onset in pediatric anti-NMDAR encephalitis. Future large-scale studies should explore its potential as an individualized biomarker, which may offer diagnostic and prognostic value beyond conventional imaging.

#2

[18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis.

Annals of clinical and translational neurology2026 Mar 24

To evaluate [18F]fluorodeprenyl-D2 ([18F]F-DED) positron-emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. [18F]F-DED PET was performed in 25 GAD65-AIE patients and 8 controls using dynamic (0-60 min) and static (30-60 min) acquisitions. Global astrogliosis was assessed by volumes of distribution (VT; 1-tissue-compartment model with carotid input) and standardized uptake values (SUV). Regional cerebellar and mesiotemporal (MT) uptake was normalized to global uptake (SUVr). PET measures were correlated with clinical phenotypes, MRI findings, and serum biomarkers (neurofilament light chain [sNfL], GAD65-Ab titers, and glial fibrillary acidic protein [sGFAP]). Clinical phenotypes included limbic encephalitis/temporal lobe epilepsy (LE/TLE; n = 17), stiff-person syndrome (n = 4), and cerebellar ataxia (CA; n = 4), with overlap in nine patients. Global [18F]F-DED uptake was higher in patients than controls. VT analysis showed increased cortical and MT uptake, while SUVr analysis demonstrated elevated MT uptake across the cohort. LE/TLE patients exhibited increased MT uptake, and CA patients showed higher cerebellar uptake. [18F]F-DED uptake did not correlate with sNfL or GAD65-Ab titers, but sGFAP showed associations with cerebellar and white-matter uptake. Regional uptake correlated with clinical severity in LE/TLE (MT lobe) and CA (cerebellar white matter). [18F]F-DED PET reveals region-specific astrogliosis corresponding to clinical manifestations and disease severity in GAD65-AIE, supporting its potential as a monitoring tool for disease activity.

#3

Population-Based Epidemiology of Autoimmune Seizures and Epilepsies.

Annals of neurology2026 Mar 24

To estimate the prevalence, incidence, and disease burden of autoimmune seizures and epilepsies in Olmsted County. We conducted a retrospective, population-based study using the Rochester Epidemiology Project (1996-2019). Age- and sex-standardized rates (2019 United States standard population) per 100,000 were calculated with 95% confidence intervals (95% CIs). Temporal trends in incidence were assessed over 3 consecutive 8-year intervals (1996-2003, 2004-2011, and 2012-2019) using Poisson regression to estimate rate ratios per period and trend. Disability-adjusted life years (DALYs), years of life lost (YLL), and years lived with disability (YLD) and 95% uncertainty intervals (95% UIs) were estimated for 2019. Twenty-three patients were identified between 1996 and 2019. In 2019, the standardized prevalence of all autoimmune seizures and epilepsies was 9.81 (95% CI, 5.59-15.21) per 100,000, including autoimmune-associated epilepsy (AAE) 7.27 (3.74-11.95) and acute symptomatic seizures secondary to autoimmune encephalitis (ASSAE) 2.55 (0.69-5.60). From 1996 to 2019, the standardized incidence was 0.50 (0.29-0.77) per 100,000 person-years overall, with AAE 0.36 (0.19-0.59) and ASSAE 0.15 (0.05-0.30). By period, the standardized incidence of all autoimmune seizures and epilepsies suggested a rising trend from 0.28 (95% CI, 0.06-0.68) in 1996 to 2003 to 0.60 (95% CI, 0.24-1.12) in 2004-2011, then plateaued at 0.53 (95% CI, 0.21-1.00) in 2012 to 2019 (rate ratio per 8-year interval 1.30, 95% CI, 0.71-2.38), largely driven by the seropositive subgroup. The standardized DALY rate was 26.27 (95% Uncertainly intervals [UI], 5.30-67.09) per 100,000 (YLL 20.07 [0.00-60.21] and YLD 6.20 [5.06-7.39]). Although autoimmune seizures and epilepsies remain rare, they result in a disproportionately high disease burden. ANN NEUROL 2026.

#4

Central nervous system pericytes express soluble ST2 in inflammation and injury.

Molecular brain2026 Mar 19

Brain pericytes are mediators of neuroinflammation, as evidenced in vitro, in animal models and humans. We and others have identified the platelet-derived growth factor (PDGF)-BB -PDGF receptor beta (PDGFRB) pathway as a key modulator of inflammatory cues in human brain pericytes. We investigate the receptor for interkeukin-33 (IL-33), interkeukin-1 receptor-like 1 (IL1RL1; also known as ST2) as a highly upregulated transcript in response to PDGF-BB stimulation in pericyte cultures. We show that pericytes express transcripts for both the membrane bound form of the receptor (ST2L) and the soluble form (sST2) that acts as a decoy and blocks IL-33 signalling. Human brain pericytes secrete sST2 in response to PDGF-BB, but also to transforming growth factor alpha (TGF) alpha and interleukin-4 (IL-4), although they are unresponsive to IL-33 treatment. We also examine pericyte expression of both IL1RL1 transcripts using RNAscope in two different in vivo models of neuroinflammation, experimental autoimmune encephalitis (EAE) and photothrombotic stroke. We present data showing that in rodents pericytes increase transcript expression predominantly for soluble IL1RL1 in inflammatory and stroke models. Our results highlight a novel expression pattern of the soluble and membrane bound forms of the IL-33 receptor in vitro and in combination with our observations in vivo suggest that cerebrovascular pericytes may negatively regulate IL-33 signalling following injury or inflammatory insults to the brain.

#5

Clinical profile and treatment outcomes of patients with chronic presentations of autoimmune encephalitis: expanding the spectrum.

BMJ neurology open2026

The spectrum of autoimmune encephalitis (AIE) is evolving due to heterogeneity of clinical syndromes associated with autoantibodies. While majority of patients present within 3 months, little is known about chronic presentations of AIE. This study aims to characterise the neurobehavioural profile and assess the long-term outcomes of patients with chronic presentations of AIE. Patients with serum or cerebrospinal fluid AIE antibody positivity were included in the study. We reviewed their clinical, cognitive, imaging and treatment characteristics as well as their long-term outcomes. Addenbrooke's Cognitive Examination-III and Clinical Dementia Rating score were used to evaluate global cognition and the severity of dementia, respectively. Of 306 patients diagnosed with dementia in a cognitive disorders' clinic, 28 had chronic presentations of AIE. The mean age of 28 patients was 55 years (range: 50-60), and mean duration of illness was 12 months (range: 3-84). Of the 28 patients, 9 (32%) were positive for leucine-rich glioma inactivated 1 antibody, 7 (25%) anti-thyroid peroxidase, 5 (18%) N-Methyl D-Aspartate receptor, 5 (18%) glutamic acid decarboxylase 65 and 2 (7%) had contactin-associated protein antibodies. Memory, language and behavioural disturbances with prominent neuropsychiatric symptoms were characteristic clinical manifestations. The course was chronic progressive, relapsing and rapidly progressive in 18 (64%), 8 (28%) and 2 (7%) patients, respectively. On immunomodulator therapy, the majority (21/28) improved, while 7/28 patients remained unchanged or experienced an exacerbation of symptoms. Chronic presentations of AIE are less known, and often misdiagnosed due to insidious progressive course and resemble degenerative dementias. A high index of suspicion in patients with chronic atypical cognitive syndromes and a low threshold for antibody testing will allow for prompt diagnosis, appropriate immunotherapy and improvement in clinical outcome.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.552 artigos no totalmostrando 199

2026

Fixel-Based Analysis of Pretreatment MRI Identifies White Matter Abnormalities in Pediatric Anti-NMDAR Encephalitis.

Journal of child neurology
2026

[18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis.

Annals of clinical and translational neurology
2026

Population-Based Epidemiology of Autoimmune Seizures and Epilepsies.

Annals of neurology
2026

Sporadic Creutzfeldt-Jakob Disease With Spinal Cord Lesions: A Case Report.

Cureus
2026

Case Report: Dual response to efgartigimod in myasthenia gravis and comorbid autoimmune disorders: a case series.

Frontiers in immunology
2026

Recommendations for a Pediatric Catatonia Clinical Pathway in Acute Medical Care Settings: A Delphi Consensus Study.

Journal of the Academy of Consultation-Liaison Psychiatry
2026

Single-institution experience with efgartigimod in patients with GFAP astrocytopathy: Treatment response and adverse events.

Multiple sclerosis and related disorders
2026

Therapeutic perspectives in refractory anti-NMDA receptor encephalitis.

The Lancet. Neurology
2026

An Atypical Presentation of Autoimmune Encephalitis.

The primary care companion for CNS disorders
2026

Anti-NMDA receptor encephalitis in the setting of inherited chromosomally integrated human herpesvirus 6B (iciHHV-6B): A case report.

IDCases
2026

Combination Versus Monotherapy in Acute Anti-LGI1 Encephalitis: A Real-World Dose Optimization Analysis.

Neuropsychopharmacology reports
2026

Central nervous system pericytes express soluble ST2 in inflammation and injury.

Molecular brain
2026

Clinical profile and treatment outcomes of patients with chronic presentations of autoimmune encephalitis: expanding the spectrum.

BMJ neurology open
2026

Acute cerebral blood flow and its connectivity in patients with anti-LGI1 autoimmune encephalitis: an arterial spin labeling study.

Brain imaging and behavior
2026

Vital Prognosis and Causes of Death in Adults with Encephalitis.

Neurocritical care
2026

Refractory anti-NMDA receptor encephalitis driven by a contralateral ovarian teratoma following unilateral oophorectomy: a case report.

International journal of surgery case reports
2026

Testing for neural antibodies in autoimmune encephalitis: who, what, where, when, why, and how.

Therapeutic advances in neurological disorders
2026

Pediatric anti-NMDAR encephalitis: Neuroradiological presentation, cognitive outcome and volumetric MRI analysis.

NeuroImage. Clinical
2026

Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortium.

Multiple sclerosis and related disorders
2026

Visual Disturbance and Elevated Glutamic Acid Decarboxylase Antibody Levels as Manifestations of Central Nervous System Lymphoma.

Neurology India
2026

Alternative diagnoses of suspected paraneoplastic neurological syndromes: a population-based study.

Journal of neurology
2026

The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management.

Advances in therapy
2026

Morvan Syndrome Masquerading as Anxiety Disorder: A Case Report Highlighting the Importance of Recognizing Organic Signs in Psychiatric Settings.

International medical case reports journal
2026

Intrathecal immunoglobulin production in the diagnosis, prognosis, and monitoring of autoimmune diseases of the central nervous system.

Journal of translational autoimmunity
2026

Neuropsychiatric Presentation of Non-paraneoplastic Voltage-Gated Calcium Channel Autoimmune Encephalitis: A Case Report.

Cureus
2026

Clinical features, prognosis, and influencing factors of relapse in autoimmune encephalitis associated with antibodies against cell surface antigens: a single-center retrospective study.

European journal of medical research
2026

Morvan syndrome associated with prominent Tau pathology: A clinicopathological case report.

Journal of neuroimmunology
2026

Non-invasive Assessment of Glymphatic System Function in Patients with Anti-LGI1 Encephalitis.

Multiple sclerosis and related disorders
2026

Anti-GAD65 Encephalitis: A Cryptic Case Requiring a Multidisciplinary Approach.

Harvard review of psychiatry
2026

Antibody-Negative Nivolumab-Induced Autoimmune Encephalitis: A Case Report and Review of Seronegative Presentations.

Cureus
2026

Severe sleep-related hypoventilation in antibody-positive and antibody-negative autoimmune encephalitis: an emergency.

The European respiratory journal
2026

Minimally Clinically Important Difference of the Clinical Assessment Scale in Autoimmune Encephalitis.

Annals of clinical and translational neurology
2026

Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report.

Frontiers in immunology
2026

[Cognitive and psychiatric evolution in autoimmune encephalitis in a school-aged child: Clinical case].

Revista medica del Instituto Mexicano del Seguro Social
2026

Deciphering Involuntary Movements: A Case of Seronegative Autoimmune Encephalitis With a Kaleidoscopic Presentation.

Cureus
2026

Headache in a Patient with Anti-Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis Responding to Rituximab.

Annals of Indian Academy of Neurology
2026

Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework.

The journal of prevention of Alzheimer's disease
2026

Machine learning model predicts prognosis in SARS-CoV-2-infected autoimmune encephalitis patients.

Multiple sclerosis and related disorders
2026

Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission.

Journal of neuroimmunology
2026

Anti-IgLON5 encephalitis is associated with anti-retinal immunological reactivity without retinal alteration.

Journal of translational autoimmunity
2026

CAR T-Cell Immunotherapy in Neuroautoimmune Diseases: Focus on the Central Nervous System.

Biomedicines
2026

Clinical features and outcomes of anti-NMDAR autoimmune-related central nervous system involvement in patients with teratoma: a retrospective cohort study.

BMC neurology
2026

Rare demyelinating diseases of the central nervous system: A diagnostic and therapeutic challenge - based on the case of a young woman with MOGAD.

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
2026

Case Report: Thymoma-associated myasthenia gravis, myositis, myocarditis, and anti-GAD65 autoimmune encephalitis: a unique case of paraneoplastic polyautoimmunity.

Frontiers in immunology
2026

Seronegative Autoimmune Encephalitis With Neuropsychiatric Presentation: A Case Report.

Cureus
2026

Autoimmune Encephalitis Associated With Anti-Contactin-Associated Protein-Like 2 (Anti-CASPR2) Antibodies in an Elderly Patient: A Case Report.

Cureus
2026

Update on pediatric autoimmune encephalitis-associated epilepsy.

Current opinion in neurology
2026

Pembrolizumab-Induced Autoimmune Encephalitis: A Rare Case.

Cureus
2026

A rare case of breakthrough tick-borne encephalitis in early adolescence after vaccination with four doses of TBE vaccine.

New microbes and new infections
2026

A qualitative exploration of patient experiences living with autoimmune encephalitis.

Scientific reports
2026

A Systematic Review and Meta-Analysis of the Recurrence of Autoimmune Encephalitis.

Annals of clinical and translational neurology
2026

Reversible bilateral striatal lesions in NPSLE.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

C-reactive protein-to-albumin ratio predicts intensive care admission and disease severity in autoimmune encephalitis.

Frontiers in immunology
2026

Clinical response to therapeutic plasma exchange in patients with immune-mediated inflammatory diseases of the central nervous system.

Anales de pediatria
2026

Delayed-Onset Acute Chorea Following Anesthesia.

Journal of child neurology
2026

Beyond Autoimmune Encephalitis-Insights and Cross-Disciplinary Lessons.

JAMA neurology
2026

Lentiform fork sign mimicking uremic encephalopathy in an atypical case of autoimmune limbic encephalitis.

Radiology case reports
2026

Case Report: Anti-neural cell adhesion molecule 1 antibody-positive encephalitis presenting with schizophrenia-like symptoms and an ovarian teratoma.

Frontiers in immunology
2026

[A case of autoantibody-negative autoimmune encephalitis associated with mature ovarian teratoma, successfully treated with early ovariectomy].

Rinsho shinkeigaku = Clinical neurology
2026

Anti-GABA-AR encephalitis or neuropsychiatric SLE? Avoiding misdiagnosis through comprehensive antibody testing beyond commercial panels.

Practical neurology
2026

Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 Pandemic.

Neurology(R) neuroimmunology & neuroinflammation
2026

FDG-PET Associations With Disease Severity and Outcomes in NMDA-Receptor IgG Autoimmune Encephalitis.

Annals of clinical and translational neurology
2026

Soluble TREM2 Is Elevated in Pediatric Patients with Anti-NMDAR Encephalitis.

Journal of clinical medicine
2026

Abnormal Magnetic Resonance Imaging Patterns in Patients with Neuropsychiatric Disorders Due to Anti-NMDA Receptor Encephalitis: A Comparative Study.

Diagnostics (Basel, Switzerland)
2026

Disease models of anti-N-methyl-d-aspartate receptor encephalitis: Investigating pathogenesis and targeted therapy.

Experimental neurology
2026

Pediatric new-onset super refractory status epilepticus: Potential of timely immunotherapy in a resource-limited PICU.

Seizure
2026

Infection-triggered encephalopathy syndrome in children: a neuroimaging perspective.

Pediatric radiology
2026

Case Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease.

Frontiers in neuroscience
2026

Case Report: Pediatric Hallucinations and Anti-Neuronal Intermediate Filament Autoimmune Encephalitis.

Clinical practice and cases in emergency medicine
2026

Consider autoimmune encephalitis in cases of headache, dizziness, and mild pleocytosis following SARS-CoV-2 infection.

Neurological research and practice
2026

Autoimmune encephalitis associated with anti-recoverin antibodies.

Journal of medical case reports
2026

Anti-gad autoimmune encephalitis: a case report.

BMC neurology
2026

Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.

JAMA neurology
2026

CSF Leukocytes in Intracranial Infections: Diagnostic, Mechanistic, and Therapeutic Insights for Neurocritical Care.

Cellular and molecular neurobiology
2026

Brain imaging reveals hierarchical topology changes and stage-dependent impairments in autoimmune encephalitis.

Journal of neurology
2026

Characteristics of and risk factors for epilepsy after autoimmune and infectious encephalitis.

BMC neurology
2026

Simultaneous perfusion and dopaminergic imaging using dual-isotope CZT SPECT/CT in dementia with Lewy bodies.

EJNMMI research
2026

Long-term cognitive outcomes and persistent executive dysfunction in LGI1 autoimmune encephalitis.

Journal of the neurological sciences
2025

Immune checkpoint inhibitor-induced AMPA2 antibody-positive encephalitis: a case report.

Frontiers in oncology
2026

Case Report: Recurrent anti-glutamic acid decarboxylase 65 antibody-associated encephalitis in a child.

Frontiers in immunology
2026

Systemic and organ-specific autoantibodies and worse outcomes in autoimmune encephalitis: a multicenter cohort study.

Frontiers in immunology
2026

Adolescent autoimmune encephalitis with dual positive anti-Drebrin and anti-mGluR2 antibodies: a case report.

Frontiers in immunology
2026

CASPR2 antibody-related neurological syndromes in children: three cases report and literature review.

BMC pediatrics
2026

A patient with anti-IgLON5 disease associated with cerebral hemorrhage, multiple ischemic strokes, and kidney failure: case report.

Journal of neurology
2026

[A case of anti-leucine-rich glioma inactivated protein 1 (LGI1) antibody-positive autoimmune encephalitis with electrographic seizures without epileptic seizure symptoms].

Rinsho shinkeigaku = Clinical neurology
2026

Paraneoplastic Encephalitis Unmasking Small-Cell Lung Cancer With Impending Superior Vena Cava Obstruction: A Case Report.

Cureus
2026

Microbial-Immune Interplay in CNS Autoimmune Diseases: Lessons from Animal Models and Clinical Studies.

European journal of immunology
2026

Anti-AMPAR limbic encephalitis as the initial presentation of metastatic small cell cancer.

BMJ case reports
2025

Autoimmune encephalitis associated with antibodies against intracellular antigens in children.

Frontiers in immunology
2026

Anti-LGI-1 autoimmune encephalitis: Insights from literature and a very late-onset case report.

Clinical neurology and neurosurgery
2026

Autoimmune-associated epilepsy or acute symptomatic seizures? A case series of recurrent seizures in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

Epilepsy research
2026

Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome: A Case Report and Review of a Rare Delayed Complication of Cranial Irradiation.

Clinical case reports
2025

Diagnostic biomarkers for differentiating AQP4-IgG- negative NMOSD from other nervous system autoimmune disorders: a retrospective study.

Frontiers in immunology
2025

Anti-NMDA receptor encephalitis unmasking Sjögren's disease: a case report and literature review.

Frontiers in immunology
2026

Clinical Phenotypes and Prognosis of Anti-mGluR1 Encephalitis: A Single-Center Case Series and Comprehensive Literature Review.

Diagnostics (Basel, Switzerland)
2026

Seizure burden and treatment efficacy evaluation in anti-LGI1 autoimmune encephalitis patients using wearable device: a pilot feasibility study.

BMJ neurology open
2025

Impact of sex differences on clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis during the acute phase: a single-center retrospective study.

Frontiers in human neuroscience
2026

Anti-mGluR encephalitis: case series and literature review.

BMC neurology
2026

Clinical, imaging, and immunological features of GFAP astrocytopathy: a systematic review with regional comparison.

Multiple sclerosis and related disorders
2026

Neuroinflammation in GAD65 Antibody-Associated Epilepsy Measured Using [18F]DPA-714 PET/MRI.

Annals of clinical and translational neurology
2026

Mimics and Diagnostic Pitfalls of Anti-Adenylate Kinase 5 Limbic Encephalitis.

CNS neuroscience & therapeutics
2026

Infection as a potential trigger in glial fibrillary acidic protein astrocytopathy: a case report and review of immunotherapeutic strategies.

BMC neurology
2026

TMEM132A autoimmunity in patients with suspected autoimmune cerebellar ataxia.

Journal of neuroimmunology
2026

Paraneoplastic Neurological Syndromes: Advances and Future Perspectives in Immunopathogenesis and Management.

Antibodies (Basel, Switzerland)
2026

New-onset refractory status epilepticus associated with Sjögren's disease.

BMJ neurology open
2026

Clinical decision-making in relation to autoimmunity: insights from catatonia and autoimmune encephalitis.

BJPsych open
2026

Screening for neuronal antibodies in cognitive impairment and dementia clinics: a prospective multicenter study.

BMC neurology
2025

Autoimmune encephalitis with LGI1 antibodies: a report of two cases.

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
2026

Racial and Ethnic Disparities in Clinical Characteristics and Outcomes in Adults With Encephalitis: A Retrospective Study.

Journal of central nervous system disease
2025

Efficacy and safety of blood purification in the treatment of autoimmune encephalitis: a meta-analysis.

American journal of translational research
2026

Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progression.

Brain : a journal of neurology
2026

Cryo-EM of autoantibody-bound NMDA receptors reveals antigenic hotspots in an active immunization model of anti-NMDAR encephalitis.

Science advances
2026

Machine learning and multi-omics integration identifies immunological predictors and mechanistic insights in autoimmune encephalitis.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]
2026

Methylglyoxal-modification of NLRP3 interrupts NLRP3-NEK7 interaction diminishing inflammasome activation and neuroinflammation.

Journal of neuroinflammation
2026

Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS neurologic diseases.

Handbook of clinical neurology
2026

Immunotherapies on autoimmune encephalitis.

Handbook of clinical neurology
2026

Autoimmune encephalitis, autoimmune dementias, and autoimmune psychotic disorders.

Handbook of clinical neurology
2026

The evolution and current status of anti-B-cell therapies in autoimmune neurologic diseases.

Handbook of clinical neurology
2026

Rapidly progressive sensorineural hearing loss due to sporadic Creutzfeldt-Jakob disease.

BMJ case reports
2026

Optimized NMDAR autoantibody detection via combined NR1-4a LCBA and NR1/NR2 fusion FCBA.

Clinica chimica acta; international journal of clinical chemistry
2026

The Gut Feeling Behind Autoimmune Encephalitis.

Epilepsy currents
2025

Case Report: Creutzfeldt-Jakob disease and diagnosis challenges: case report and evidence synthesis.

F1000Research
2026

Brain and neural cell type proteomics reveal extracellular matrix proteins enriched in progressive multiple sclerosis.

Nature communications
2026

Systematic Review and Meta-Analysis of the Clinical Features Associated With Seronegative Autoimmune Encephalitis.

Neurology(R) neuroimmunology & neuroinflammation
2026

Relative Frequency and Distinctive Features of Anti-Ma2 Nonparaneoplastic Neurologic Disorders: A French Cohort Study.

Neurology(R) neuroimmunology & neuroinflammation
2025

Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Viral Encephalitis: A Case Report and Literature Review.

Cureus
2025

Aseptic Meningitis and Papillary Edema: Uncommon Presentation of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Cureus
2026

Three Challenging Cases of Autoimmune Encephalitis: A Case-Series and a Review of the Literature.

Clinical case reports
2026

The spectrum of movement disorders in neurosyphilis: A systematic review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

The First Case of Bacillus Calmette-Guérin-Induced Autoimmune Encephalitis.

IJU case reports
2026

Multivariate Risk-Factor Analysis of Short-Term Poor Prognosis in Children With Autoimmune Encephalitis.

Journal of child neurology
2026

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.

The Lancet regional health. Europe
2025

Autoimmune Encephalitis in Pregnancy: A Case Report.

Cureus
2025

Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma.

Cureus
2026

Fatal retroperitoneal hemorrhage following enoxaparin administration in a patient with autoimmune encephalitis: a case report.

Encephalitis (Seoul, Korea)
2026

IL6 blockade: an effective approach in steroid-refractory immune checkpoint inhibitor-related neuropathies requiring ICI rechallenge-case report.

ESMO open
2026

Deciphering autoimmune encephalitis: Immune mechanisms, therapeutic paradigms, and global research trends.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Autoimmune Psychosis Exists: Early Diagnosis of an Anti-NMDA Receptor Autoimmune Encephalitis Presenting as First-Episode Psychosis in a 25-Year-Old Male-A Case Report.

Case reports in psychiatry
2026

Evaluating the Clinical Impact of Metagenomic Next-Generation Sequencing in CNS Infections: A Diagnostic Pathway and Resource Utilization Modeling Study.

Open forum infectious diseases
2025

Anti-LGI1 encephalitis: clinical presentation, imaging features, and prognostic analysis.

Frontiers in neurology
2025

Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score.

Epilepsia
2025

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of Its Pharmacological Profile, Clinical Utility, and Expanding Applications.

Biomedicines
2026

Immature ovarian teratomas in anti-NMDA receptor encephalitis.

Journal of neuroimmunology
2025

Early psychiatric manifestations in pediatric autoimmune encephalitis: clinical data from a tertiary center.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Rituximab in the Intensive Care Unit: A Review of Indications and Clinical Considerations.

Journal of intensive care medicine
2025

Progress in the preparation of an active immunization model of anti-N-methyl-D-aspartate receptor encephalitis in animals.

Frontiers in immunology
2025

Progressive Supranuclear Palsy With Post-traumatic Frontal Lobe Damage Mimicking Anti-IgLON5 Antibody Disease.

Cureus
2025

Rare Variants of Immune-Related Genes Increase Susceptibility to Autoimmune Encephalitis: An Association Study.

Neurology international
2025

Anti-AMPA receptor limbic encephalitis as the initial manifestation of metastatic breast cancer.

BMJ case reports
2025

Cardiac involvement in anti-GABA-B receptor encephalitis: a case report.

BMJ neurology open
2026

Comprehensive Review on the Neuro-ophthalmic Manifestations of Autoimmune Encephalitis Syndromes.

International ophthalmology clinics
2025

Beyond the Psychiatric Lens: Difficulties in Diagnosing Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Psychiatric Presentation.

Cureus
2025

Coexistence of anti-neurexin-3α-associated autoimmune encephalitis and systemic lupus erythematosus in an adult patient: a case report.

Frontiers in immunology
2025

Double Filtration Plasmapheresis Shows Superior Short-Term Efficacy to Intravenous Methylprednisolone in Acute Autoimmune Encephalitis: A Prospective Observational Study.

Drug design, development and therapy
2025

A rare presentation of herpes simplex virus type 2 encephalitis following primary genital herpes in an immunocompetent female: An unusual case.

Indian journal of sexually transmitted diseases and AIDS
2025

Anti-NMDA receptor encephalitis with coexisting autoimmune GFAP astrocytopathy presenting with psychiatric symptoms leading to a suicide attempt: a case report.

International journal of emergency medicine
2025

Rasmussen encephalitis without atrophy and increased 11C-methionine PET uptake mimicking glioma: A case report.

The neuroradiology journal
2026

Astrocyte Biology in CNS Inflammatory Diseases: A Clinical-Translational Perspective.

Neurology(R) neuroimmunology & neuroinflammation
2025

Brain atrophy in autoimmune encephalitis: epidemiology, pathophysiology, clinical manifestations, treatment, and prognosis-an update.

Journal of neurology
2025

18F- FDG PET Reveals a Nucleus Accumbens-Centered Metabolic Network Correlating With Clinical Severity in Anti-LGI1 Encephalitis.

MedComm
2025

Severe anti-NMDA receptor encephalitis in a pediatric patient presenting with status dystonicus as the primary clinical manifestation: A case report (CARE).

Medicine
2025

The gut-brain axis: potential reshaping the future of anti-NMDAR encephalitis treatment.

Frontiers in immunology
2025

Intermittent immunoadsorption in critically ill patients with neuroimmunological disorders: a retrospective study.

Frontiers in neurology
2026

Personalized Ofatumumab therapy for autoimmune encephalitis: A case series of four patients.

Journal of neuroimmunology
2026

Rapidly progressive dementia in a middle-aged woman: A case of probable sporadic Creutzfeldt-Jakob disease.

Medicine international
2026

A EIF2AK2 missense variant misdiagnosed as autoimmune encephalitis.

Parkinsonism & related disorders
2025

ANTIBODY-POSITIVE AUTOIMMUNE ENCEPHALITIS WITH ANTI-GAD65, ANTI-GABAARΑ1, AND ANTI-MGLUR5 ANTIBODIES: A CASE REPORT AND LITERATURE REVIEW.

Georgian medical news
2025

Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer.

OncoTargets and therapy
2025

Research trends on herpes simplex encephalitis in children: a bibliometric analysis from 1975 to 2024.

Translational pediatrics
2026

Comparative [18F]Florzolotau and [18F]FDG PET Imaging Patterns in Anti-IgLON5 Disease and Progressive Supranuclear Palsy.

Clinical nuclear medicine
2025

Anti-IgLON5 Disease: A Systematic Review and Meta-Analysis.

European journal of neurology
2025

[Temporal lobe seizures of immune and structural etiology].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2025

International evaluation of the SEIZUre Risk in Encephalitis (SEIZURE) score for predicting acute seizure risk.

BMJ open
2025

Rapidly Progressive Dementia: Predictive Clues and a Proposed Diagnostic Approach Focused on Neurodegenerative Causes.

Cureus
2025

Electroceuticals for Motherhood: Utility of responsive neurostimulation and Proactive antiseizure medication management in two pregnancies.

Epilepsy & behavior reports
2025

A Case Report of Anti-GAD65 Antibody-Positive Autoimmune Encephalitis Associated with Diabetes.

Endocrine, metabolic & immune disorders drug targets
2026

Biomarkers of neuroaxonal and astrocytic pathology in autoimmune encephalitis.

Brain, behavior, and immunity
2025

Neurological immune-related adverse events of immune checkpoint inhibitors: clinical and hematological risk factors.

Journal of neurology
2026

Clinical Criteria to Guide Antineuronal Antibody Testing for People With Early and Persistent Psychosis Attending Mental Health Services.

Biological psychiatry global open science
2025

Neuropsychiatric Symptoms After HHV-6 Encephalitis in an Immunocompetent Child: A Case Report.

The American journal of case reports
2025

Bilateral thalamic encephalitis due to Epstein-Barr virus in an elderly patient: a case report and literature review.

BMC neurology
2025

Basal Ganglia Calcification With Treatment-Resistant Hypocalcaemia and Persistent Psychosis in an 18-Year-Old: A Case Report.

Cureus
2026

Experience of bortezomib use in refractory autoimmune neurological disorders.

Multiple sclerosis and related disorders
2026

Gut-derived Helicobacter rodentium aggravates Tfh/Tfr imbalance and neuroinflammation via PI3K/AKT activation in anti-NMDAR encephalitis mice.

Tissue & cell
2026

Autoimmune glial fibrillary acidic protein astrocytopathy following human herpesvirus-7 infection: a case report.

Brain injury
2025

The evolving etiologies of rapidly progressive dementia: a systematic review.

Translational psychiatry
2026

Intrathecal Epstein-Barr virus reactivation in patients with autoimmune glial fibrillary acidic protein astrocytopathy.

Journal of neurology, neurosurgery, and psychiatry
2026

Autoimmune encephalitis in first episode psychosis: Prospective non-interventional longitudinal study in tertiary psychiatric center.

Journal of neuroimmunology
2025

Differential Diagnosis of Infectious Versus Autoimmune Encephalitis Using Artificial Intelligence-Based Modeling.

Journal of clinical medicine
2025

Seronegative Immune-Mediated Cerebellar Ataxia in Children: Autoimmune Encephalitis Spectrum Disorder or a Distinct Entity?

Children (Basel, Switzerland)
2025

Complications of Therapeutic Plasma Exchange in Pediatric Neuroimmune Disorders.

Children (Basel, Switzerland)
2025

Differentiation between anti-CASPR2 encephalitis with initial psychiatric symptoms and primary psychiatric disorders, and a diagnostic prediction model: a prospective descriptive study.

Journal of neurology
2025

An Unusual Case of Refractory Seizures.

The Journal of the Association of Physicians of India
2025

Sez6L2 autoimmunity induces cerebellar ataxia in mice.

Journal of neuroinflammation
2026

Prior murine neurotropic coronavirus infection ameliorates experimental autoimmune encephalitis.

Journal of autoimmunity
2025

Overlapping autoimmune encephalitis with tripartite autoantibody positivity (NMDAR, GFAP, mGluR5) associated with papillary thyroid carcinoma: a case report.

BMC neurology
2025

Therapeutic Plasma Exchange in Pediatric Care: Insights from a Tertiary Care Centre Experience.

Indian pediatrics
2025

Case Report: Co-occurring de novo SHANK3 and SRCAP variants in a patient with autoimmune encephalitis and exhibiting Phelan-McDermid syndrome features.

Frontiers in genetics
2025

Case Report: KLHL11 encephalitis in a female patient with dual primary malignancies of breast and lung cancer: response to FcRn inhibitor therapy.

Frontiers in immunology
Ver todos os 1.552 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Encefalite autoimune.

É de uma associação que acompanha esta doença? Fale com a gente →

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A condição é causada por uma inflamação no cérebro resultante de um ataque do próprio sistema imunológico contra o tecido cerebral. Não há genes hereditários catalogados para essa doença, estando frequentemente associada à produção de autoanticorpos neuronais específicos.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 5 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:622014
    Orphanet
  2. GARD:11979
    GARD (NIH)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Encefalite autoimune. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/encefalite-autoimune

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Encefalite autoimune

ORPHA:622014 · MONDO:0020640
Ensaios
36 ativos
Medicamentos
4 registrados
MedGen
UMLS
C5671289
EuropePMC
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Moléculas estudadas na doença
fonte: OpenTargets
Rara